metastatic colorectal cancer
FDA Approves Lumakras With Vectibix for KRAS G12C–Mutated Colorectal Cancer
The FDA has approved sotorasib with panitumumab for adult patients with KRAS G12C–mutated metastatic CRC.
JANUARY 24, 2025

FDA Grants Accelerated Approval to Braftovi for Some Patients With Metastatic Colorectal Cancer
The FDA granted accelerated approval to encorafenib with cetuximab and mFOLFOX6 for patients with mCRC.
JANUARY 2, 2025

New First-Line Option for Highly Mutated CRC?
The dual immunotherapy combination of nivolumab plus ipilimumab reduced the risk for disease progression or death ...
MARCH 12, 2024

FDA Approves Fruzaqla in Refractory Metastatic Colorectal Cancer
The FDA approved fruquintinib (Fruzaqla, Takeda) for some previously treated adults with metastatic colorectal ...
NOVEMBER 15, 2023
